- Home
- OBIO vs SIFY Comparison
OBIO vs SIFY Comparison
Compare OBIO & SIFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- SIFY
- Stock Information
- Founded
- OBIO 2017
- SIFY 1995
- Country
- OBIO United States
- SIFY India
- Employees
- OBIO N/A
- SIFY N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- SIFY Computer Software: Programming Data Processing
- Sector
- OBIO Health Care
- SIFY Technology
- Exchange
- OBIO Nasdaq
- SIFY Nasdaq
- Market Cap
- OBIO 200.1M
- SIFY 232.6M
- IPO Year
- OBIO N/A
- SIFY 1999
- Fundamental
- Price
- OBIO $4.90
- SIFY $3.24
- Analyst Decision
- OBIO Strong Buy
- SIFY
- Analyst Count
- OBIO 4
- SIFY 0
- Target Price
- OBIO $15.75
- SIFY N/A
- AVG Volume (30 Days)
- OBIO 53.8K
- SIFY 79.8K
- Earning Date
- OBIO 11-12-2024
- SIFY 01-16-2025
- Dividend Yield
- OBIO N/A
- SIFY N/A
- EPS Growth
- OBIO N/A
- SIFY N/A
- EPS
- OBIO N/A
- SIFY N/A
- Revenue
- OBIO $2,647,000.00
- SIFY $443,027,157.00
- Revenue This Year
- OBIO $12.39
- SIFY N/A
- Revenue Next Year
- OBIO $120.99
- SIFY $12.52
- P/E Ratio
- OBIO N/A
- SIFY $60.04
- Revenue Growth
- OBIO N/A
- SIFY 5.85
- 52 Week Low
- OBIO $4.22
- SIFY $1.80
- 52 Week High
- OBIO $10.46
- SIFY $12.30
- Technical
- Relative Strength Index (RSI)
- OBIO 43.91
- SIFY 48.05
- Support Level
- OBIO $4.78
- SIFY $3.06
- Resistance Level
- OBIO $5.84
- SIFY $3.64
- Average True Range (ATR)
- OBIO 0.42
- SIFY 0.20
- MACD
- OBIO -0.04
- SIFY -0.03
- Stochastic Oscillator
- OBIO 24.24
- SIFY 22.22
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About SIFY Sify Technologies Limited
Sify Technologies Ltd is a provider of corporate network services in India. It offers converged Information and Communication Technology (ICT) solutions comprising Network- Connectivity services, Data Center services and Digital Services which include Cloud and Managed services, Applications Integration services and Technology Integration services. The company operates in three segments; Network Connectivity services which consists of domestic data, international data, wholesale voice. Data Center Services which consists of co-location services, cross connects and other allied managed services. Digital Services which consists of Cloud and Managed Services, Network Managed Services, Applications Integration Services, Technology Integration Services. Key revenue is from Network.